Skip to content
Search

Latest Stories

E-pharmacies in India and Kenya ‘not fully’ compliant with regulatory requirements

Only 16% of Indian e-pharmacies provide complete drug information
In India, e-pharmacies currently account for 2–3% of total medicine sales, a figure anticipated to increase to 15% over the next ten years. (gettyimages)

Only 16% of Indian e-pharmacies and 42% of those in Kenya provide complete drug information

E-pharmacies in India and Kenya demonstrate low compliance with global best practices and existing or proposed national regulations, a new study has revealed.

Published in PLOS Global Public Health, the study found that none of the assessed e-pharmacies in either country was fully compliant with regulatory requirements.


On average, e-pharmacies serving Kenya met 8.9 out of 12 (74 per cent) of the country’s regulatory requirements, while those serving India complied with 7.5 out of 14 (54 per cent) ‘proposed requirements.’

The research was conducted by the George Institute for Global Health in India, in collaboration with Strathmore Business School in Kenya and the London School of Hygiene & Tropical Medicine.

E-pharmacies were defined as businesses selling prescription-only medicines (POMs) directly to consumers through websites or apps.

The study identified 61 websites and 37 apps catering to Indian consumers, alongside 26 websites and three apps serving Kenyan users.

Researchers assessed these platforms against global ‘best practice’ standards, as well as existing national regulations in Kenya and ‘proposed requirements’ from local guidelines and draft bills in India, where there are no e-pharmacy-specific regulations.

Key findings include:

  • A facility to upload prescriptions was provided by 90% of websites serving India and 58% serving Kenya.
  • Only 16% of Indian e-pharmacies and 42% of Kenyan e-pharmacies provided complete drug information, including indications, side effects, drug interactions, and contraindications.
  • Only 31% websites serving Kenya and none serving India displayed required registration numbers.
  • Despite regulations and guidelines, 62% of e-pharmacies in Kenya and 34% in India listed narcotic or controlled drugs for sale.
  • All websites serving India, and all but one serving Kenya, complied with the practice of prohibiting advertisements of POMs.

The study also found that high-traffic websites and e-pharmacies located within the study country had higher mean compliance to regulation and best practices compared to the others.

The researchers highlighted the need for a robust regulatory framework to ensure consumer safety and and maintain the quality of pharmaceutical care in the rapidly growing e-pharmacy sector in both countries.

“The study findings can be leveraged to strengthen regulatory enforcement in Kenya and inform the development of legislation and accompanying regulations for e-pharmacies in India,” they noted.

They recommend a risk-based approach to regulation, where regulators work with the largely compliant (“good”) e-pharmacies, improve enforcement among the partially compliant (“bad”), and eliminate the largely non-compliant (“ugly”).

The study cautioned that poorly regulated e-pharmacy could expose consumers to health and e-commerce-related risks.

Over the past decade, the global e-pharmacy market has witnessed significant expansion. Valued at USD 92 billion (£74.25 billion) in 2023, it is projected to surpass USD 350 billion (£282.48 billion) by 2033, with emerging markets driving the majority of this growth.

In India, e-pharmacies currently account for 2–3% of total medicine sales, a figure anticipated to increase to 15% over the next ten years.

Meanwhile, Africa’s e-pharmacy sector has seen remarkable growth, tripling from USD 190 million in 2019 (pre-COVID-19) to USD 560 million in 2022.

The African e-pharmacy market tripled from a pre-COVID-19 value of USD 190 million (£153.34 million) in 2019 to USD 560 million (451.96 million) in 2022.

More For You

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025

The Single Activity Fee (SAF) was increased by 19p to £1.46 per item, effective from April 2024.

gettyimages

19p SAF increase to be included in April and May 2025 advance payments

Following discussions with the Department of Health and Social Care (DHSC), Community Pharmacy England (CPE) has agreed a mechanism that will allow pharmacy owners to receive the 19p increase to the Single Activity Fee (SAF) earlier for the dispensing months of April and May 2025.

CPE said: “The advance payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance payments will be required from the June 2025 dispensing month onwards.”

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less